These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15245891)

  • 1. Pharmacoscintigraphic evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans.
    Sato Y; Kawashima Y; Takeuchi H; Yamamoto H; Fujibayashi Y
    J Control Release; 2004 Jul; 98(1):75-85. PubMed ID: 15245891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of riboflavin-containing microballoons for floating controlled drug delivery system in healthy human volunteers.
    Sato Y; Kawashima Y; Takeuchi H; Yamamoto H
    J Control Release; 2003 Nov; 93(1):39-47. PubMed ID: 14602420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans.
    Sato Y; Kawashima Y; Takeuchi H; Yamamoto H
    Int J Pharm; 2004 May; 275(1-2):97-107. PubMed ID: 15081141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method.
    Sato Y; Kawashima Y; Takeuchi H; Yamamoto H
    Eur J Pharm Biopharm; 2004 Mar; 57(2):235-43. PubMed ID: 15018980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process.
    Hamdani J; Goole J; Moës AJ; Amighi K
    Int J Pharm; 2006 Oct; 323(1-2):86-92. PubMed ID: 16815656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites.
    Akiyama Y; Nagahara N; Nara E; Kitano M; Iwasa S; Yamamoto I; Azuma J; Ogawa Y
    J Pharm Pharmacol; 1998 Feb; 50(2):159-66. PubMed ID: 9530983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of dual controlled release microballoons containing riboflavin and citric acid: in vitro and in vivo evaluation.
    Singh AN; Pathak K
    J Microencapsul; 2011; 28(5):442-54. PubMed ID: 21554157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stomach specific polymeric low density microballoons as a vector for extended delivery of rabeprazole and amoxicillin for treatment of peptic ulcer.
    Choudhary S; Jain A; Amin MCIM; Mishra V; Agrawal GP; Kesharwani P
    Colloids Surf B Biointerfaces; 2016 May; 141():268-277. PubMed ID: 26859118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and characterization of floating microballoons of nizatidine for effective treatment of gastric ulcers in murine model.
    Jain A; Pandey V; Ganeshpurkar A; Dubey N; Bansal D
    Drug Deliv; 2015 May; 22(3):306-11. PubMed ID: 24601855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroretentive dosage forms.
    Moës AJ
    Crit Rev Ther Drug Carrier Syst; 1993; 10(2):143-95. PubMed ID: 8370085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citric acid prolongs the gastro-retention of a floating dosage form and increases bioavailability of riboflavin in the fasted state.
    Stops F; Fell JT; Collett JH; Martini LG; Sharma HL; Smith AM
    Int J Pharm; 2006 Feb; 308(1-2):14-24. PubMed ID: 16343829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of riboflavin from a gastric retention formulation.
    Ahmed IS; Ayres JW
    Int J Pharm; 2007 Feb; 330(1-2):146-54. PubMed ID: 17034968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery.
    Jain SK; Agrawal GP; Jain NK
    AAPS PharmSciTech; 2006 Nov; 7(4):90. PubMed ID: 17233542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hollow microspheres for use as a floating controlled drug delivery system in the stomach.
    Kawashima Y; Niwa T; Takeuchi H; Hino T; Itoh Y
    J Pharm Sci; 1992 Feb; 81(2):135-40. PubMed ID: 1372046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel riboflavin gastro-mucoadhesive delivery system based on ion-exchange fiber.
    Yao H; Xu L; Han F; Che X; Dong Y; Wei M; Guan J; Shi X; Li S
    Int J Pharm; 2008 Nov; 364(1):21-6. PubMed ID: 18761065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Floating microspheres of carvedilol as gastro retentive drug delivery system: 3(2) full factorial design and in vitro evaluation.
    Nila MV; Sudhir MR; Cinu TA; Aleykutty NA; Jose S
    Drug Deliv; 2014 Mar; 21(2):110-7. PubMed ID: 24028280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method.
    Sato Y; Kawashima Y; Takeuchi H; Yamamoto H
    Eur J Pharm Biopharm; 2003 May; 55(3):297-304. PubMed ID: 12754004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humans.
    Kagan L; Lapidot N; Afargan M; Kirmayer D; Moor E; Mardor Y; Friedman M; Hoffman A
    J Control Release; 2006 Jul; 113(3):208-15. PubMed ID: 16806558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs.
    Klausner EA; Lavy E; Stepensky D; Friedman M; Hoffman A
    Pharm Res; 2002 Oct; 19(10):1516-23. PubMed ID: 12425470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of novel site specific hollow floating microspheres bearing 5-Fu for stomach targeting.
    Bhardwaj P; Chaurasia D; Singh R; Swarup A
    ScientificWorldJournal; 2014; 2014():705259. PubMed ID: 25383377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.